Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: A pilot study

Human Psychopharmacology

Volumn 25, Issue 2, 2010, Pages 139-144

  Nakano, Yuichiro ^a   Yoshimura, Reiji ^a   Nakano, Hideki ^a   Ikenouchi Sugita, Atsuko ^a   Hori, Hikaru ^a   Umene Nakano, Wakako ^a   Ueda, Nobuhisa ^a   Nakamura, Jun ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Nitric oxide; Risperidone; Schizophrenia

Indexed keywords

BENZODIAZEPINE DERIVATIVE; NITRIC OXIDE; RISPERIDONE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; MALE; MENTAL PATIENT; PATHOPHYSIOLOGY; PILOT STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA; SCORING SYSTEM; SYMPTOM;

ADULT; ANTIPSYCHOTIC AGENTS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; PILOT PROJECTS; RISPERIDONE; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 77749339841     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1102     Document Type: Article

References (31)

1. Akyol O, Zoroglu SS, Armutcu F, Sahin S, Gurel A. 2004. Nitric oxide as a physiopathological factor in neuropsychiatric disorders. In Vivo 18: 377-390.
2. Andreasen NC, Rezai K, Alliger R, et al. 1992. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 49: 943-958.
3. Baranano DE, Snyder SH. 2001. Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc Natl Acad Sci U S A 98: 10996-11002.
4. Bernstein HG, Bogert B, Keilhoff G. 2005. The many faces of nitric oxide in schizophrenia. A review. Schizophr Res 78: 69-86.
5. Bird DC, Bujas-Bobanovic M, Robertson HA, Dursun SM. 2001. Lack of phencyclidine-induced effects in mice with reduced neuronal nitric oxide synthase. Psychopharmacology 155: 299-309.
6. Brenman JE, Bredt DS. 1997. Synaptic signaling by nitric oxide. Curr Opin Neurobiol 7: 374-378.
7. Carlsson A, Hansson LO, Waters N, Carlsson ML. 1999. A glutamatergic deficiency model of schizophrenia. Br J Psychiatry Suppl 37: 2-6.
8. Carpenter WT, Heinrichs DW, Wagman AM. 1988. Deficit and non-deficit forms of schizophrenia: the concept. Am J Psychiatry 145: 27-41.
9. Fossier P, Blanchard B, Ducrocq C, Leprince C, Tauc L, Baux G. 1999. Nitric oxide transforms serotonin into an inactive form and this affects neuromodulation. Neuroscience 93: 597-603.
10. Garthwaitte J, Garthwaite G, Palmer RM, Moncada S. 1989. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol 172: 413-416.
11. Ghasemi A, Zahediasl S, Azizi F. 2010. Reference values for serum nitric oxide metabolites in an adult population. Clin Biochem 43: 89-94.
12. Goto N, Yoshimura R, Kakeda S, et al. 2009. Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPA) and negative symptoms or cognitive impairments in early-stage schizophrenia. Hum Psychopharmacol 24: 639-645.
13. Harvey BH, Bothma T, Nel A, Wegener G, Stein DJ. 2005. Involvement of the NMDA receptor, NO-cyclic GMP and nuclear factor K-beta in an animal model of repeated trauma. Hum Psychopharmacol 20: 367-373.
14. Herken H, Uz E, Ozyurt H, Akyol O. 2001. Red blood cell nitric oxide levels in patients with schizophrenia. Schizophr Res 52: 289-290.
15. Herken H, Akyol O, Yilmaz HR, et al. 2006. Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alternations by antidepressant treatment. Hum Psychopharmacol 21: 53-59.
16. Horn PS, Feng L, Li Y, Pesse AJ. 2001. Effect of outliers and nonhealthy individuals on reference interval estimation. Clin Chem 47: 2137-2145.
17. Ikenouchi-Sugita A, Yoshimura R, Hori H, Umene-Nakano W, Ueda N, Nakamura J. 2009. Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: Comparison between milnacipran and paroxetine. Prog Neuropsychopharmacol Biol Psychiatry 33: 1451-1453.
18. Jedlickova V, Paluch Z, Alsik S. 2002. Determination of nitrate and nitrite by high-performance liquid chromatography in human plasma. J Chromatogr B 780: 193-197.
19. Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261-276.
20. Lee BH, Kim YK. 2008. Reduced plasma nitric oxide metabolites before and after antipsychotic treatment in patients with schizophrenia compared with controls. Schizophr Res 104: 36-43.
21. Liddle PF, Friston KJ, FrithCD,Hirsh SR, Jones T, FrackowiakRS. 1992. Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 160: 179-186.
22. Montague PR, Gancayco CD,Winn MJ, Marchase RB, Friedlander J. 1994. Role of NO production in NMDA receptor-mediated neurotransmittter release in cerebral cortex. Science 263: 973-977.
23. Osawa Y, Davila JC. 1993. Phencyclidine, a psychometric agent and drug abuse, is a suicide inhibitor of brain nitric oxide synthase. Biochem Biophys Res Commun 194: 1435-1439.
24. Sams-Dodd F. 1998. Effects of continuous D-amphetamine and phencyclidine administration on social behavior, stereotyped behavior, and locomotor activity in rats. Neuropsychopharmacology 19: 18-25.
25. Snitz BE, MacDonald A 3rd, Cohen JD, Cho RY, Becker T, Carter CS. 2005. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment. Am J Psychiatry 162: 2322-2329.
26. Suzuki E, Nakaki T, Nakamuta M, Miyaoka H. 2003. Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia. J Psychiatry Neurosci 28: 288-292.
27. Taneli F, Piridar S, Akdeniz F, Uyanik BS, Ari Z. 2004. Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia. Arch Med Res 35: 401-405.
28. Tsikas D. 2007. Analysis of nitrite and nitrate in biological fluids by assays based on the Greiss reaction: appraisal of the Greiss reaction in the L-arginine/nitric oxide area of research. J Chromatogr B 851: 51-70.
29. Yemolaieva O, Brot N, Weissbach H, Heinemann SH, Hoshi T. 2000. Reactive oxygen species and nitric oxide mediate plasticity of neural calcium signaling. Proc Natl Acad Sci U S A 97: 448-453.
30. Yilmaz N, Herken H, Cicek HK, Celic A, Yurekli M, Akyol O. 2007. Increased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophrenia. Med Princ Pract 16: 137-141.
31. Xing G, Chavko M, Zhang LX, Yang S, Post RM. 2002. Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression. Schzophr Res 58: 21-30.